Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
May 4, 2020

Coronavirus company news summary – Philips Foundation delivers mobile isolation care units to Italy – NGen announces investment of $14.9m for Covid-19 fighting technologies

By Chloe Kent

Philips Foundation has supplied two mobile isolation care units to the Italian Red Cross to aid Covid-19 patients, with support from Philips Italy, AFAS Foundation and Noaber Foundation. The units arrived from the Netherlands and reached Italy the previous week, and will be sent to Sardinia and Lombardy. These units are expected to expand the capacity of the care local health facilities, aid patient screening and hospitalisation and offer first aid and quality assistance to patients who may be infected and are confirmed to have Covid-19.

Roche has received the Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its new Elecsys Anti-SARS-CoV-2 antibody test. This test is expected to identify if a patient has been exposed to the Covid-19 causing SARS-CoV-2 virus and if the body has developed antibodies to fight against SARS-CoV-2. The company has commenced shipping of the new antibody test to laboratories around the world.

NGen has invested over C$21m ($14.9m) in projects that can increase the production of critically needed technologies, equipment and medical devices in Canada to boost the fight against Covid-19. After the company announced the funding programme, it received over 900 expressions of interest. It has approved projects relating to the manufacturing of ventilators and SARS-CoV-2 assays, among others.

Trax Management Services has launched its EUA-approved Covid-19 test kit. The test, PhoenixDx 2019-nCoV, is a real-time Qualitative RT-PCR that can detect the virus and provide results in less than 120 minutes. RT-PCR is said to be faster with a lower probability of contamination or errors as the test is done in a closed tube.

Related Companies

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 
Ensuring quality and supply chain visibility for medical device components

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU